Clari Vest Asset Management LLC Nektar Therapeutics Transaction History

Clari Vest Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 05, 2019	BUY	$30.43 - $56.65 $182 - $339	6 New	6 $0
Q3 2018 Nov 07, 2018	SELL	$46.46 - $68.49 $799,112 - $1.18 Million	-17,200 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$46.25 - $104.45 $2.37 Million - $5.34 Million	-51,159 Reduced 74.84%	17,200 $839,000
Q1 2018 May 08, 2018	BUY	$57.4 - $108.44 $1.15 Million - $2.18 Million	20,100 Added 41.65%	68,359 $7.26 Million
Q4 2017 Feb 13, 2018	BUY	$23.02 - $60.5 $1.11 Million - $2.92 Million	48,259	48,259 $2.88 Million

147

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $201M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.